Healthcare provider profile · identity verified

Mary L Cameron, MD

Internal Medicine · FARIBAULT, MN · NPI 1073576203

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	587	162
Levothyroxine Sodium	Levothyroxine Sodium	499	126
Amlodipine Besylate	Amlodipine Besylate	487	146
Gabapentin	Gabapentin	408	123
Metoprolol Succinate	Metoprolol Succinate	366	98
Rosuvastatin Calcium	Rosuvastatin Calcium	348	114
Lisinopril	Lisinopril	330	97
Losartan Potassium	Losartan Potassium	286	88
Pantoprazole Sodium	Pantoprazole Sodium	260	79
Eliquis	Apixaban	250	49
Omeprazole	Omeprazole	244	76
Metformin Hcl Er	Metformin Hcl	216	66
Furosemide	Furosemide	213	67
Escitalopram Oxalate	Escitalopram Oxalate	198	58
Hydrochlorothiazide	Hydrochlorothiazide	180	52
Metoprolol Tartrate	Metoprolol Tartrate	173	47
Warfarin Sodium	Warfarin Sodium	171	41
Tamsulosin Hcl	Tamsulosin Hcl	169	48
Spironolactone	Spironolactone	158	50
Tramadol Hcl	Tramadol Hcl	148	36
Carvedilol	Carvedilol	145	47
Simvastatin	Simvastatin	145	39
Famotidine	Famotidine	141	50
Atenolol	Atenolol	140	42
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	136	40
Fluticasone Propionate	Fluticasone Propionate	135	57
Pravastatin Sodium	Pravastatin Sodium	134	43
Valsartan	Valsartan	134	39
Alendronate Sodium	Alendronate Sodium	132	48
Duloxetine Hcl	Duloxetine Hcl	120	37
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	115	18
Allopurinol	Allopurinol	102	35
Buspirone Hcl	Buspirone Hcl	102	32
Trazodone Hcl	Trazodone Hcl	97	34
Jardiance	Empagliflozin	95	25
Meloxicam	Meloxicam	89	25
Potassium Chloride	Potassium Chloride	89	32
Sertraline Hcl	Sertraline Hcl	83	26
Mirtazapine	Mirtazapine	81	21
Ozempic	Semaglutide	81	19
Lorazepam	Lorazepam	80	28
Torsemide	Torsemide	79	26
Glipizide Er	Glipizide	76	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	76	15
Venlafaxine Hcl Er	Venlafaxine Hcl	74	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	73	22
Celecoxib	Celecoxib	72	28
Albuterol Sulfate Hfa	Albuterol Sulfate	69	24
Pregabalin	Pregabalin	67	14
Oxycodone Hcl	Oxycodone Hcl	65	17
Prednisone	Prednisone	63	31
Clopidogrel	Clopidogrel Bisulfate	58	17
Glimepiride	Glimepiride	58	19
Xarelto	Rivaroxaban	56	11
Fluoxetine Hcl	Fluoxetine Hcl	54	18
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	54	13
Metformin Hcl	Metformin Hcl	53	20
Donepezil Hcl	Donepezil Hcl	51	13
Ventolin Hfa	Albuterol Sulfate	51	17
Oxybutynin Chloride Er	Oxybutynin Chloride	49	16
Tizanidine Hcl	Tizanidine Hcl	46	21
Triamcinolone Acetonide	Triamcinolone Acetonide	46	25
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	45	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	44	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	16
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	43	13
Zolpidem Tartrate	Zolpidem Tartrate	43	11
Levetiracetam	Levetiracetam	40	suppressed
Nitroglycerin	Nitroglycerin	40	28
Ropinirole Hcl	Ropinirole Hcl	40	15
Finasteride	Finasteride	38	11
Montelukast Sodium	Montelukast Sodium	38	13
Bupropion Hcl Sr	Bupropion Hcl	37	12
Hydroxyzine Hcl	Hydroxyzine Hcl	37	14
Jantoven	Warfarin Sodium	37	suppressed
Amoxicillin	Amoxicillin	36	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	12
Bupropion Xl	Bupropion Hcl	34	suppressed
Digoxin	Digoxin	34	suppressed
Valacyclovir	Valacyclovir Hcl	34	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	suppressed
Estradiol	Estradiol	32	18
Loperamide	Loperamide Hcl	32	suppressed
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Breo Ellipta	Fluticasone/Vilanterol	29	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Trulicity	Dulaglutide	29	suppressed
Irbesartan	Irbesartan	28	suppressed
Mounjaro	Tirzepatide	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Tresiba Flextouch U-200	Insulin Degludec	28	suppressed
Methotrexate	Methotrexate Sodium	27	suppressed
Propranolol Hcl Er	Propranolol Hcl	27	suppressed
Nystatin	Nystatin	26	13
Cephalexin	Cephalexin	24	20
Primidone	Primidone	24	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	12
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	18
Ezetimibe	Ezetimibe	22	suppressed
Topiramate	Topiramate	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	20
Baclofen	Baclofen	20	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	20	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	20	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	19	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Spiriva Handihaler	Tiotropium Bromide	18	suppressed
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	11
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Clonazepam	Clonazepam	15	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Calcitriol	Calcitriol	14	suppressed
Methylprednisolone	Methylprednisolone	14	12
Temazepam	Temazepam	14	suppressed
Cevimeline Hcl	Cevimeline Hcl	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Tymlos	Abaloparatide	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Nystop	Nystatin	12	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Apri	Desogestrel-Ethinyl Estradiol	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error